MX2019012085A - Composición líquida de suspensión de esmectita y método de preparación de la misma. - Google Patents
Composición líquida de suspensión de esmectita y método de preparación de la misma.Info
- Publication number
- MX2019012085A MX2019012085A MX2019012085A MX2019012085A MX2019012085A MX 2019012085 A MX2019012085 A MX 2019012085A MX 2019012085 A MX2019012085 A MX 2019012085A MX 2019012085 A MX2019012085 A MX 2019012085A MX 2019012085 A MX2019012085 A MX 2019012085A
- Authority
- MX
- Mexico
- Prior art keywords
- suspension liquid
- present
- liquid composition
- preparing same
- smectite
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
- Colloid Chemistry (AREA)
Abstract
La presente invención se refiere a una suspensión que comprende esmectita, y la suspensión de la presente invención comprende tanto un agente de suspensión polimérico como un agente de suspensión de bajo peso molecular, y así presenta alta dispersabilidad y tasa de hundimiento, facilidad de administración debido a la no alta viscosidad de una formulación, potenciado cumplimiento del fármaco mientras se toma la formulación, y alta preferencia. Además, la suspensión de la presente invención permite la dispersión uniforme en su preparación, presentando así facilidad de preparación y excelente eficiencia y, por consiguiente, tiene un excelente efecto sobre la reducción de una tasa de defecto en la producción de una preparación de suspensión.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710240595.1A CN108721325B (zh) | 2017-04-13 | 2017-04-13 | 蒙脱石混悬液及其制备方法 |
PCT/KR2018/004304 WO2018190658A1 (ko) | 2017-04-13 | 2018-04-12 | 스멕타이트 현탁액 조성물 및 이의 제조방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019012085A true MX2019012085A (es) | 2020-01-20 |
Family
ID=63793726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019012085A MX2019012085A (es) | 2017-04-13 | 2018-04-12 | Composición líquida de suspensión de esmectita y método de preparación de la misma. |
Country Status (16)
Country | Link |
---|---|
US (1) | US20200046762A1 (es) |
EP (1) | EP3610858A4 (es) |
KR (1) | KR102396351B1 (es) |
CN (2) | CN108721325B (es) |
BR (1) | BR112019021427A2 (es) |
CA (1) | CA3058879A1 (es) |
CO (1) | CO2019012428A2 (es) |
EA (1) | EA038764B1 (es) |
MA (1) | MA47041B1 (es) |
MX (1) | MX2019012085A (es) |
MY (1) | MY202378A (es) |
PH (1) | PH12019502322A1 (es) |
SA (1) | SA519410274B1 (es) |
TN (1) | TN2019000276A1 (es) |
WO (1) | WO2018190658A1 (es) |
ZA (1) | ZA201906661B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112972418B (zh) * | 2021-05-18 | 2021-08-27 | 北京金城泰尔制药有限公司 | 硝呋太尔制霉素阴道软胶囊及其制备方法 |
CN116077437A (zh) * | 2022-12-29 | 2023-05-09 | 合肥久诺医药科技有限公司 | 一种蒙脱石混悬剂及其制备方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8512345D0 (en) * | 1985-05-15 | 1985-06-19 | Scras | Anti-diarrhea compositions |
US5238881A (en) * | 1988-11-09 | 1993-08-24 | Engelhard Corporation | Stable color dispersions, their preparation and use in ceramic glazes |
US5272137A (en) * | 1992-02-14 | 1993-12-21 | Mcneil-Pfc, Inc. | Aqueous pharmaceutical suspension for pharmaceutical actives |
AU2003210812A1 (en) * | 2002-02-04 | 2003-09-02 | Pharmacia Corporation | Stable pharmaceutical composition useful for treating gastrointestinal disorders |
EP1677755A4 (en) * | 2003-10-28 | 2011-12-28 | Taro Pharmaceuticals Usa Inc | FORMULATIONS BASED ON RINGS AT THE D BORDEMENT |
US20060093629A1 (en) * | 2004-10-29 | 2006-05-04 | Buehler Gail K | Dye-free pharmaceutical suspensions and related methods |
CN101112387B (zh) * | 2007-08-06 | 2011-04-13 | 南京白敬宇制药有限责任公司 | 一种治疗非感染性腹泻的蒙脱石混悬液及其制备方法 |
CN101129326A (zh) * | 2007-08-15 | 2008-02-27 | 济南康众医药科技开发有限公司 | 一种蒙脱石混悬剂制备方法 |
EP2228054A1 (en) * | 2009-03-13 | 2010-09-15 | ITALFARMACO S.p.A. | Riluzole aqueous suspensions |
EP2386289A1 (en) * | 2010-04-29 | 2011-11-16 | Ipsen Pharma S.A.S. | Clay compositions |
CN102218078B (zh) * | 2011-04-19 | 2012-10-10 | 南京威泰珐玛兽药研究所有限公司 | 一种含有蒙脱石的利福昔明混悬液及其制备方法 |
US9486460B2 (en) * | 2014-04-29 | 2016-11-08 | The Procter & Gamble Company | Bismuth containing liquid pharmaceutical suspensions |
CN104606133A (zh) * | 2015-01-07 | 2015-05-13 | 万特制药(海南)有限公司 | 鲁拉西酮口服混悬液及其制备方法 |
CN106265724A (zh) * | 2015-06-08 | 2017-01-04 | 四川健能制药有限公司 | 蒙脱石混悬液 |
CN107198679A (zh) * | 2015-07-09 | 2017-09-26 | 河南蓝图制药有限公司 | 一种蒙脱石微丸干混悬剂及其制备方法 |
CN106606476A (zh) * | 2015-10-27 | 2017-05-03 | 康芝药业股份有限公司 | 一种布洛芬混悬滴剂及其制备方法 |
CN106281044B (zh) * | 2016-08-09 | 2018-10-30 | 西安博尔新材料有限责任公司 | 一种悬浮型水性研磨液的制备方法 |
-
2017
- 2017-04-13 CN CN201710240595.1A patent/CN108721325B/zh active Active
-
2018
- 2018-04-12 MA MA47041A patent/MA47041B1/fr unknown
- 2018-04-12 KR KR1020197029212A patent/KR102396351B1/ko active IP Right Grant
- 2018-04-12 EP EP18784969.0A patent/EP3610858A4/en active Pending
- 2018-04-12 EA EA201992353A patent/EA038764B1/ru unknown
- 2018-04-12 MY MYPI2019005876A patent/MY202378A/en unknown
- 2018-04-12 US US16/604,173 patent/US20200046762A1/en active Pending
- 2018-04-12 WO PCT/KR2018/004304 patent/WO2018190658A1/ko unknown
- 2018-04-12 BR BR112019021427A patent/BR112019021427A2/pt unknown
- 2018-04-12 MX MX2019012085A patent/MX2019012085A/es unknown
- 2018-04-12 CA CA3058879A patent/CA3058879A1/en active Pending
- 2018-04-12 TN TNP/2019/000276A patent/TN2019000276A1/en unknown
- 2018-04-12 CN CN201880001604.4A patent/CN109414407B/zh active Active
-
2019
- 2019-10-09 ZA ZA2019/06661A patent/ZA201906661B/en unknown
- 2019-10-09 SA SA519410274A patent/SA519410274B1/ar unknown
- 2019-10-10 PH PH12019502322A patent/PH12019502322A1/en unknown
- 2019-11-06 CO CONC2019/0012428A patent/CO2019012428A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
EA201992353A1 (ru) | 2020-03-03 |
PH12019502322A1 (en) | 2020-07-06 |
CN109414407A (zh) | 2019-03-01 |
BR112019021427A2 (pt) | 2020-05-05 |
CO2019012428A2 (es) | 2020-01-17 |
EP3610858A4 (en) | 2020-09-02 |
SA519410274B1 (ar) | 2022-06-05 |
ZA201906661B (en) | 2020-08-26 |
KR20190130589A (ko) | 2019-11-22 |
KR102396351B1 (ko) | 2022-05-10 |
TN2019000276A1 (en) | 2021-05-07 |
MY202378A (en) | 2024-04-24 |
EA038764B1 (ru) | 2021-10-15 |
CA3058879A1 (en) | 2018-10-18 |
CN109414407B (zh) | 2020-08-25 |
MA47041A1 (fr) | 2020-04-30 |
MA47041B1 (fr) | 2020-12-31 |
CN108721325B (zh) | 2020-03-06 |
US20200046762A1 (en) | 2020-02-13 |
WO2018190658A1 (ko) | 2018-10-18 |
EP3610858A1 (en) | 2020-02-19 |
CN108721325A (zh) | 2018-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021007794A (es) | Composiciones y metodos para aplicaciones oftalmicas y/u otras aplicaciones. | |
MX2015012414A (es) | Sal de omecamtiv mecarbilo y proceso para preparar la sal. | |
HRP20191366T4 (hr) | Injekcijski pripravak | |
TN2018000395A1 (en) | New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them | |
MY174692A (en) | Finasteride and minoxidil polymeric nonoparticle, its process of preparation, aqueous suspension containing the same, pharmaceutical composition, and its use | |
NZ708824A (en) | Tetracycline topical formulations, preparation and uses thereof | |
SI2958913T1 (sl) | Sfingozin-1-fosfat receptor agonisti, postopki za njegovo pripravo in farmacevtski sestavki, ki ga vsebujejo kot aktivno sredstvo | |
UA116993C2 (uk) | Полімерна наночастинка фінастериду та фармацевтична композиція, що її містить | |
PH12019550088A1 (en) | Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery | |
PH12016500814A1 (en) | Heteroaryl butanoic acid derivatives | |
IN2013MU03583A (es) | ||
PH12019502322A1 (en) | Smectite suspension liqiud composition and method for preparing same | |
GB201200192D0 (en) | Methotrexate composition | |
MY173159A (en) | Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer | |
MX2017014340A (es) | Suspension acuosa que contiene nanoparticulas de glucocorticosteroide. | |
MY192813A (en) | Aqueous formulation comprising paracetamol and ibuprofen | |
MX2016005764A (es) | Formulacion en suspension acuosa que comprende nanoparticulas de antibioticos macrolidos. | |
WO2015073177A8 (en) | Vaginal inserted estradiol pharmaceutical compositons and methods | |
MX359887B (es) | Composicion masticable para administracion oral y proceso para preparar la misma. | |
MY164822A (en) | Pharmaceutical compositions of carotenoid | |
EA032385B9 (ru) | Фармацевтическая композиция для лечения заболеваний желудочно-кишечного тракта | |
MX2019015869A (es) | Nuevas formulaciones orales de belinostat. | |
WO2016008401A8 (zh) | 一种含多西他赛的药物组合物 | |
SG10201810362SA (en) | Anti-allergic agent, agent for improving allergic diarrhea and pharmaceutical composition | |
NZ631461A (en) | Novel veterinary pharmaceutical compositions and method for the production thereof |